Trademark Overview
On Thursday, April 9, 2026, a trademark application was filed for OZEMPIC with the United States Patent and Trademark Office. The USPTO has given the OZEMPIC trademark a serial number of 79450358. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 21, 2026. This trademark is owned by Novo Nordisk A/S. The OZEMPIC trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of liver diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension; pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases; pharmaceutical preparations for the treatment of neurological disorders, including alcohol dependence and alzheimer's disease; pharmaceutical preparations for the treatment of psychiatric disorders, including depression and anxiety.
